We help customers make informed drug development decisions on safety and efficacy, risk assessments and mitigation, and study designs by providing FDA/EMA drug approval and comparative drug safety data.
PharmaPendium serves critical data needs of preclinical and clinical scientists focused on drug development and safety
From designing the best preclinical and clinical studies to perform, to drug safety assessments and pharmacovigilance, we help scientists and other professionals focused on drug candidate characterization and development make more informed decisions and save time.
We serve a global customer base that includes the world's leading and most cutting-edge pharmaceutical and biotech companies. PharmaPendium users include scientists and other practitioners who work with DMPK, pharmacodynamics, safety pharmacology, clinical pharmacology, translational and clinical research, modelling and simulation groups, regulatory affairs and pharmacovigilance.
Drug Discovery & Development
You can have better risk mitigation strategies if you can depend on the information that you've found. The more information you have, the more informed choices you can make and most probably the more intelligent programs you can make in your project. PharmaPendium helps us to make better, more informed decisions. Laura Newman, Scientist at Major Pharmaceutical Company
Read the case study (PDF, 0.542 MB)
We help customers identify, understand and avert potential safety concerns with searchable FDA/EMA drug approval and comparative drug safety data.
The key to avoiding DDIs
Today, drug-drug interactions (DDIs) account for 3-5% of all reported adverse drug reactions. Find out how to best identify potential DDIs and assess their risk.